Earthquake rocks Los Angeles
A 4.4 magnitude earthquake rocked the Los Angeles region early Monday afternoon.
Related Articles
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma | Research To Practice
Friday, December 6, 2024, San Diego, California, 3:15 PM – 5:15 PM PT (6:15 PM – 8:15 PM ET) Program Schedule — Pacific Time 2:45…
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial
Stereotactic body radiotherapy (SBRT) is increasingly used to treat early-stage non-small cell lung cancer (NSCLC) in medically inoperable patients. Excellent rates of local control (87 %-95 %)…
The AI-Empowered Oncologist: A Look Back at ASCO24 Research to Improve Clinical Use
The use of artificial intelligence (AI) was a central theme at the 2024 ASCO Annual Meeting, including many tools, such as large language models, clinical…
Creating a World Where Precision Oncology is a Reality for All
Vivek Subbiah, MD, of Sarah Cannon Research Institute, explains what areas need to be addressed to make precision oncology more accessible.
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer – OncoDaily
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer / cancer, dMMR/MSI-H Rectal Cancer, Dostarlimab, FDA, OncoDaily, Oncology,
Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics – OncoDaily
Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics / Alvaro Sebastian, Aurélien Marabelle, cancer,
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non‐seminomatous germ cell tumour
Objectives To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a,…
Impact of Financial Toxicity on Treatment Adherence and Quality of Life in Pancreatic Cancer | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) is increasingly recognized as a major issue in cancer care. We evaluated the prevalence and risk factors for FT in patients with…
Pancreatic ductal adenocarcinoma staging: a narrative… : International Journal of Surgery
lving tools in select patients. The National Comprehensive Cancer Network (NCCN) guidelines define resectability criteria based on tumor involvement of the arteries and veins and…
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation
Nature Cancer – Mellman and colleagues present a multiomic single-cell analysis of the effects of combined anti-TIGIT and anti-PD-1 blockade on T cell populations trafficking…